Skip to main content

Dynavax Technologies(DVAX-Q)
NASDAQ

Today's Change
Delayed Last Update

Dynavax Technologies

2100 Powell Street Suite 720
Emeryville CA 94608 USA
P: 510-848-5100
F: 510-848-1327
http://www.dynavax.com

Sectors & Indices

Sector
Industry
Employees

    Profile

    Dynavax Technologies discovers, develops, and intends to commercialize innovative products to treat and prevent allergies, infectious diseases, and chronic inflammatory diseases using versatile, proprietary approaches that alter immune system responses in highly specific ways. Dynavax's clinical development programs are based on immunostimulatory sequences which are short DNA sequences that enhance the ability of the immune system to fight disease and control chronic inflammation.

    Key Executives

    NameTitle
    David NovackCOO/President
    Robert JanssenChief Medical Officer/Senior VP, Divisional

    More from The Globe